Premium
Successful Ovulation Induction, Conception, and Normal Delivery after Chronic Therapy with Etanercept: A Recombinant Fusion Anti‐cytokine Treatment for Rheumatoid Arthritis
Author(s) -
SILLS E.S.,
PERLOE MARK,
TUCKER MICHAEL J.,
KAPLAN CAROLYN R.,
PALERMO GIANPIERO D.
Publication year - 2001
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1034/j.1600-0897.2001.d01-25.x
Subject(s) - etanercept , medicine , rheumatoid arthritis , ovulation , tumor necrosis factor alpha , ovulation induction , infertility , pregnancy , immunology , arthritis , endocrinology , biology , hormone , genetics
Etanercept (Enbrel®; Wyeth‐Ayerst/Immunex Inc, Seattle, WA, USA) is a subcutaneously administered novel fusion protein consisting of the extracellular ligand‐binding domain of the 75 kD receptor for tumor necrosis factor‐alpha (anti‐TNFα) and the F C portion of human IgG1. The agent is synthesized by plasmid transfection of a Chinese hamster ovary cell line, utilizing recombinant DNA technology. Etanercept was approved by the US FDA for treatment of multi‐drug resistant rheumatoid arthritis in 1998, but no human data exist regarding the impact of anti‐TNFα therapy on human reproductive function or its use before ovulation induction. As TNFα potentiates collagenolysis via matrix metalloproteinase gene expression (thereby facilitating ovulation), there exists a theoretical risk that TNFα‐inhibition could exert an undesirable effect on ovulation and pregnancy. In this report, we describe the first case of ovulation induction, intrauterine insemination, normal pregnancy and singleton delivery of a healthy infant following chronic (>1 year) pre‐ovulatory TNFα‐inhibitor therapy for rheumatoid arthritis. Reproductive endocrinologists and obstetrician‐gynecologists should be familiar with etanercept therapy in the context of severe rheumatic disease, and offer appropriate reassurance regarding its safe use for infertility patients planning ovulation induction.